Efficiency of Adding Omalizumab to Standard Therapy for Children with Recurrent Spontaneous Urticaria: Comparative Observational Study
Background. Recurrent spontaneous urticaria (RSU) is rare in children, thus, it is debilitating condition that always requires treatment. There are several limitations on the drugs use in children with RSU. Omalizumab is the effective medication for achieving the control of RSU, used in adolescents...
Gardado en:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Russo |
| Publicado: |
Union of pediatricians of Russia
2020-08-01
|
| Series: | Педиатрическая фармакология |
| Assuntos: | |
| Acceso en liña: | https://www.pedpharma.ru/jour/article/view/1858 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|